Anpario (LON:ANP) Posts Quarterly Earnings Results

Anpario (LON:ANP) announced its quarterly earnings results on Wednesday. The company reported GBX 22.45 EPS for the quarter, Digital Look Earnings reports. Anpario had a return on equity of 17.05% and a net margin of 14.53%.

Anpario Stock Down 2.6%

Shares of ANP stock traded down GBX 12.50 during mid-day trading on Friday, hitting GBX 460. 43,166 shares of the stock traded hands, compared to its average volume of 45,453. Anpario has a 52-week low of GBX 391.11 and a 52-week high of GBX 580. The stock has a market cap of £74.92 million, a P/E ratio of 12.12 and a beta of 1.08. The company has a debt-to-equity ratio of 0.60, a current ratio of 6.29 and a quick ratio of 5.16. The stock’s fifty day moving average is GBX 528.04 and its two-hundred day moving average is GBX 515.69.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on ANP shares. Canaccord Genuity Group increased their target price on shares of Anpario from GBX 570 to GBX 600 and gave the stock a “buy” rating in a report on Friday. Shore Capital Group reaffirmed a “house stock” rating on shares of Anpario in a research report on Monday, August 17th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of GBX 600.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.